Welcome to LookChem.com Sign In|Join Free
  • or
2-cyano-N-(2-furylmethyl)acetamide is a chemical compound belonging to the acetamide class, characterized by its molecular formula C10H10N2O2. It features a cyano group and a furanyl group in its structure, which contribute to its diverse chemical reactivity and potential pharmacological properties. 2-cyano-N-(2-furylmethyl)acetamide is commonly utilized in organic synthesis and pharmaceutical research, and may also be involved in the development of new drugs and agrochemicals. Due to its potential health and environmental risks, it is crucial to handle 2-cyano-N-(2-furylmethyl)acetamide with care and follow safety protocols.

59749-85-8

Post Buying Request

59749-85-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

59749-85-8 Usage

Uses

Used in Organic Synthesis:
2-cyano-N-(2-furylmethyl)acetamide is used as a key intermediate in organic synthesis for its versatile chemical reactivity, allowing for the creation of various complex organic molecules.
Used in Pharmaceutical Research:
In pharmaceutical research, 2-cyano-N-(2-furylmethyl)acetamide is utilized as a starting material or building block for the development of new drugs, owing to its potential pharmacological properties.
Used in Drug Development:
2-cyano-N-(2-furylmethyl)acetamide is employed as a component in the development of innovative drugs, leveraging its chemical structure to target specific biological pathways or mechanisms.
Used in Agrochemical Development:
2-cyano-N-(2-furylmethyl)acetamide may also be used in the agrochemical industry for the development of new pesticides or other agricultural chemicals, given its potential to interact with biological systems.
Used in Research and Development (R&D) Laboratories:
2-cyano-N-(2-furylmethyl)acetamide is used in R&D laboratories for studying its chemical properties and exploring its applications in various fields, including material science and chemical engineering.

Check Digit Verification of cas no

The CAS Registry Mumber 59749-85-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,7,4 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 59749-85:
(7*5)+(6*9)+(5*7)+(4*4)+(3*9)+(2*8)+(1*5)=188
188 % 10 = 8
So 59749-85-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O2/c9-4-3-8(11)10-6-7-2-1-5-12-7/h1-2,5H,3,6H2,(H,10,11)

59749-85-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-cyano-N-(furan-2-ylmethyl)acetamide

1.2 Other means of identification

Product number -
Other names F3097-4575

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:59749-85-8 SDS

59749-85-8Relevant academic research and scientific papers

Non-alkylator anti-glioblastoma agents induced cell cycle G2/M arrest and apoptosis: Design, in silico physicochemical and SAR studies of 2-aminoquinoline-3-carboxamides

Yuan, Pengtao,Gu, Xiangyu,Ni, Xintong,Qi, Yingxue,Shao, Xusheng,Xu, Xiaoyong,Liu, Jianwen,Qian, Xuhong

supporting information, (2021/09/22)

Malignant gliomas are the most common brain tumors, with generally dismal prognosis, early clinical deterioration and high mortality. Recently, 2-aminoquinoline scaffold derivatives have shown pronounced activity in central nervous system disorders. We herein reported a series of 2-aminoquinoline-3-carboxamides as novel non-alkylator anti-glioblastoma agents. The synthesized compounds showed comparable activity to cisplatin against glioblastoma cell line U87 MG in vitro. Among them, we found that 6a displayed good inhibitory activity against A172 and U118 MG glioblastoma cell lines and induced cell cycle arrest in the G2/M phase and apoptosis in U87 MG by flow cytometry analysis. Additionally, 6a displayed low cytotoxicity to several normal human cell lines. In silico study showed 6a had promising physicochemical properties and was predicted to cross the blood–brain barrier. Moreover, preliminary structure–activity relationships are also investigated, shedding light on further modifications towards more potent agents on this series of compounds. Our results suggest this compound has a promising potential as an anti-glioblastoma agent with a differential effect between tumor and non-malignant cells.

Chemical Evolution of Antivirals Against Enterovirus D68 through Protein-Templated Knoevenagel Reactions

Tauber, Carolin,Wamser, Rebekka,Arkona, Christoph,Tügend, Marisa,Abdul Aziz, Umer Bin,Pach, Szymon,Schulz, Robert,Jochmans, Dirk,Wolber, Gerhard,Neyts, Johan,Rademann, J?rg

, p. 13294 - 13301 (2021/05/10)

The generation of bioactive molecules from inactive precursors is a crucial step in the chemical evolution of life, however, mechanistic insights into this aspect of abiogenesis are scarce. Here, we investigate the protein-catalyzed formation of antivirals by the 3C-protease of enterovirus D68. The enzyme induces aldol condensations yielding inhibitors with antiviral activity in cells. Kinetic and thermodynamic analyses reveal that the bioactivity emerges from a dynamic reaction system including inhibitor formation, alkylation of the protein target by the inhibitors, and competitive addition of non-protein nucleophiles to the inhibitors. The most active antivirals are slowly reversible inhibitors with elongated target residence times. The study reveals first examples for the chemical evolution of bio-actives through protein-catalyzed, non-enzymatic C?C couplings. The discovered mechanism works under physiological conditions and might constitute a native process of drug development.

X-ray Structure and Molecular Docking Guided Discovery of Novel Chitinase Inhibitors with a Scaffold of Dipyridopyrimidine-3-carboxamide

Yuan, Pengtao,Jiang, Xi,Wang, Siyu,Shao, Xusheng,Yang, Qing,Qian, Xuhong

, p. 13584 - 13593 (2020/12/02)

Chitinases are the glycosyl hydrolase for catalyzing the degradation of chitin and play an indispensable role in bacterial pathogenesis, fungal cell wall remodeling, and insect molting. Thus, chitinases are attractive targets for therapeutic drugs and pes

Synthesis of new thiazole, bithiazolidinone and pyrano [2,3-d] thiazole derivatives as potential antimicrobial agents

Salem, Mohamed A.

, p. 1 - 9 (2017/05/29)

In an attempt to find a new class of antimicrobial agents, a series of thiazole derivatives containing furan moiety 3, 7, 8a,b, 10a-c and 12 were prepared via the reaction of 2-cyano-N-(furan-2-ylmethyl)acetamide (1) with phenyl isothiocyanate and α-halocarbonyl compounds. Also, many bithiazolidinone and pyranothiazole derivatives were synthesized through interaction of thiazolidinone 7 with appropriate electrophilic reagents. These compounds were screened for their antibacterial and antifungal activity. Among the synthesized compounds, thiazole derivatives 23a and 23b were equipotent to gentamycin against K. pneumonia (MIC 0.49 μg/mL), and showed in vitro antifungal activity equipotent to amphotericin B versus A. fumigatus (MIC 0.98 μg/mL), A. clavatus (MIC 0.98 μg/mL) and G. candidium (MIC 0.49 μg/mL). Also, bithiazolidinones 14 and 15 were equipotent to amphotericin B in inhibiting the growth of A. clavatus (MIC 0.98 μg/mL) and G. candidium (MIC 0.49 μg/mL). Structures of the newly synthesized compounds were established by elemental analysis and spectral data.

Discovery and structure-activity relationships of small molecules that block the human immunoglobulin G-human neonatal Fc receptor (hIgG-hFcRn) protein-protein interaction

Wang, Zhaolin,Fraley, Cara,Mezo, Adam R.

, p. 1253 - 1256 (2013/03/14)

The neonatal Fc receptor, FcRn, prolongs the half-life of IgG in the serum and represents a potential therapeutic target for the treatment of autoimmune disease. Small molecules that block the protein-protein interactions of human IgG-human FcRn may lower pathogenic autoantibodies and provide effective treatment. A novel class of quinoxalines has been discovered as antagonists of the IgG:FcRn protein-protein interaction through optimization of a hit derived from a virtual ligand-based screen.

2-cyano-2-alkoximino-acetamides

-

, (2008/06/13)

Novel fungicides of the formula STR1 in which R1 represents optionally substituted hydroxyalkyl, optionally substituted hydroxyalkoxyalkyl, optionally substituted heteroarylalkyl or optionally substituted heteroaryl, and R2 represents optionally substituted alkyl, optionally substituted alkenyl, or alkinyl. Intermediate therefor, wherein R2 is hydrogen or an alkali metal cation, are also new.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 59749-85-8